# Novartis Venture Fund: portfolio, investments and team

> Novartis Venture Fund is a corporate vc based in Switzerland. 153 investments on record, 4 in the last 12 months, latest Jul 2026.

Source: https://millionrounds.com/fund/novartis-venture-fund (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Investor](https://millionrounds.com/investors)

# Novartis Venture Fund

Last cheque observed Jul 2026; 153 cheques on record.

Email

Deploying now Corporate VC

Seed Series A Series B Molecules Drug Pharma

Follow Novartis Venture Fund and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fnovartis-venture-fund)

Deploying now

**80%** of best year **4** **cheques in 12 months**, 153 on record

Since the last cheque **116** days **00** hrs **00** min **00** sec

Median round **$52M** Rounds led **5 of 153** Sole investor **1 rounds** Exits **14 from the portfolio** Mostly in **United States, 68%**

Pitch Novartis Venture Fund

## Novartis Venture Fund highlights

- 01 4 cheques in the last 12 months
- 02 Mostly Series B and Series A: 68% of its rounds
- 03 Sole investor in 1 rounds, median $1.7M
- 04 14 exits from the portfolio

## What they do

> The Novartis Venture Fund was created to foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies. From their own website

- **Type:** Corporate VC (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Molecules Drug Pharma
- **Based in:** Cambridge, Switzerland
- **Cold pitches:** Not accepted

## The record

Every round we can evidence, newest first **153 appearances**

- **2026** 3 rounds
- **Jul** **[FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics)** Series D · US · Ventureburn **$67M** With 15 others
- **Apr** **[Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics)** Series B · US · Ventureburn **$137M** *Led*
- **Jan** **[EpiBiologics](https://millionrounds.com/company/epibiologics)** Series B · US · Avego Management **$107M** With 11 others
- **2025** 2 rounds
- **Dec** **[Protego Biopharma](https://millionrounds.com/company/protego-biopharma)** Series B · US · Firms' own news pages **$130M** *Led*
- **Sept** **[NRG Therapeutics](https://millionrounds.com/company/nrg-therapeutics)** Series B · GB · Firms' own news pages **$68M** With 6 others
- **2024** 1 round
- **Mar** **[Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics)** Series B · US · Firms' own news pages **$175M** With 15 others
- **2023** 1 round
- **Oct** **[AstronauTx](https://millionrounds.com/company/astronautx)** Series A · GB · UCL Technology Fund **$61M** *Led*
- **2022** 1 round
- **Mar** **[Epsilogen Ltd.](https://millionrounds.com/company/epsilogen-ltd)** Series B · GB · UCL Technology Fund **$41M** *Led*
- **2019** 4 rounds
- **Nov** **[Immunitas](https://millionrounds.com/company/immunitas)** Series A · US · FinSMEs **$39M** *Led*
- **Sept** **[Anokion](https://millionrounds.com/company/anokion)** Series B · CH · FinSMEs **$40M** With 2 others
- **Aug** **[Renovacor](https://millionrounds.com/company/renovacor)** Series A · US · FinSMEs **$11M** With 4 others
- **Jul** **[Tscan Therapeutics](https://millionrounds.com/company/tscan-therapeutics)** Series B · US · FinSMEs **$48M** With 4 others
- **2017** 3 rounds
- **May** **[Lemonaid Health](https://millionrounds.com/company/lemonaid-health)** Series A · US · FinSMEs **$11M** With 3 others
- **May** **[Vivet Therapeutics](https://millionrounds.com/company/vivet-therapeutics)** Series A · FR · FinSMEs **$39M** With 1 other
- **Jan** **[Expansion](https://millionrounds.com/company/expansion)** Series A · US · FinSMEs **$55M** With 4 others
- **2016** 1 round
- **Sept** **[ROX Medical](https://millionrounds.com/company/rox-medical)** Series E · US · FinSMEs **$40M** With 1 other
- **2015** 13 rounds
- **Oct** **[Galera Therapeutics](https://millionrounds.com/company/galera-therapeutics)** Series B · US **$37M** With 4 others
- **Sept** **[Proteostasis Therapeutics](https://millionrounds.com/company/proteostasis-therapeutics)** Series B · US **$37M** With 7 others
- **Jul** **[Ra Pharmaceuticals](https://millionrounds.com/company/ra-pharmaceuticals)** Series B · US **$59M** With 8 others
- **Jul** **[GenSight Biologics](https://millionrounds.com/company/gensight-biologics)** Series B · FR **$36M** With 8 others
- **Jun** **[Autonomic Technologies](https://millionrounds.com/company/autonomic-technologies)** Series D · US **$43M** With 7 others
- **Jun** **[MyoPowers Medical Technologies](https://millionrounds.com/company/myopowers-medical-technologies)** Series C · CH **$5.1M** With 2 others
- **May** **[Autonomic Technologies](https://millionrounds.com/company/autonomic-technologies)** Series D · US **$38M** With 4 others
- **Apr** **[Merus](https://millionrounds.com/company/merus)** Series C · NL **$79M** With 10 others
- **Mar** **[Aeglea BioTherapeutics](https://millionrounds.com/company/aeglea-biotherapeutics)** Series B · US **$44M** With 4 others
- **Mar** **[Macrolide Pharmaceuticals](https://millionrounds.com/company/macrolide-pharmaceuticals)** Series A · US **$22M** With 3 others
- **Feb** **[Merganser Biotech](https://millionrounds.com/company/merganser-biotech)** Series A · US **$28M** With 4 others
- **Feb** **[Vaxin](https://millionrounds.com/company/vaxin)** Venture · US **$16M** With 3 others
- **Jan** **[Atlas Genetics](https://millionrounds.com/company/atlas-genetics)** Series C · GB **$20M** With 5 others
- **2014** 18 rounds
- **Dec** **[Annexon](https://millionrounds.com/company/annexon)** Series A · US **$34M** With 2 others
- **Nov** **[BioNano Genomics](https://millionrounds.com/company/bionano-genomics)** Series C · US **$53M** With 4 others
- **Oct** **[Aileron Therapeutics](https://millionrounds.com/company/aileron-therapeutics)** Series E · US **$33M** With 6 others
- **Oct** **[Quartet Medicine](https://millionrounds.com/company/quartet-medicine)** Series A · GB **$17M** With 2 others
- **Oct** **[Forendo Pharma](https://millionrounds.com/company/forendo-pharma)** Series A · FI **$15M** With 1 other
- **Oct** **[Viamet Pharmaceuticals](https://millionrounds.com/company/viamet-pharmaceuticals)** Series D · US **$60M** With 4 others
- **Oct** **[Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics)** Series A · GB **$32M** With 4 others
- **Aug** **[Seventh Sense Biosystems](https://millionrounds.com/company/seventh-sense-biosystems)** Series B · US **$16M** With 4 others
- **Aug** **[Galera Therapeutics](https://millionrounds.com/company/galera-therapeutics)** Series A · US **$4.7M** With 2 others
- **May** **[Sorbent Therapeutics](https://millionrounds.com/company/sorbent-therapeutics)** Series D · US **$6.5M** With 4 others
- **May** **[Anokion SA](https://millionrounds.com/company/anokion-sa)** Series A · CH **$38M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

We hold **15** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **14 in all**

**[Immune Targeting Systems](https://millionrounds.com/company/immune-targeting-systems)** Bought by Vaxin **Undisclosed** Feb 2015

**[Alios BioPharma](https://millionrounds.com/company/alios-biopharma)** Bought by [Johnson & Johnson](https://millionrounds.com/fund/johnson-and-johnson) **$1.8B** Sept 2014

**[Covagen](https://millionrounds.com/company/covagen)** Bought by Cilag **Undisclosed** Aug 2014

**[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013

**[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$60M** Oct 2012

**[Intellikine](https://millionrounds.com/company/intellikine)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$310M** Dec 2011

**[EraGen Biosciences](https://millionrounds.com/company/eragen-biosciences)** Bought by Luminex **$34M** Jun 2011

**[Foldrx Pharmaceuticals](https://millionrounds.com/company/foldrx-pharmaceuticals)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Sept 2010

**[Intradigm Corporation](https://millionrounds.com/company/intradigm-corporation)** Bought by [Silence Therapeutics](https://millionrounds.com/fund/silence-therapeutics) **Undisclosed** Dec 2009

**[Omeros](https://millionrounds.com/company/omeros)** Listed **Undisclosed** Oct 2009

**[Visiogen](https://millionrounds.com/company/visiogen)** Bought by [Abbott Labs](https://millionrounds.com/fund/abbott-labs) **$400M** Sept 2009

**[Ablation Frontiers](https://millionrounds.com/company/ablation-frontiers)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **Undisclosed** Feb 2009

**[Amphora Discovery](https://millionrounds.com/company/amphora-discovery)** Bought by Nanosyn **Undisclosed** Jul 2008

**[Glycart Biotechnology AG](https://millionrounds.com/company/glycart-biotechnology-ag)** Bought by Roche **Undisclosed** Jul 2005

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$52M** the round, not its cheque Alone, median **$1.7M**

Led 5 of 153 rounds **3%**

- **Sole investor:** 1 rounds
- **Last cheque:** Jul 2026
- **Exits:** 14 from the portfolio

Rounds by stage said on their site

- Series B said *52*
- Series A said *50*
- Series C *19*
- Venture *12*
- Series D *12*
- Series E *5*
- Seed said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) 15
- [Apple Tree Partners](https://millionrounds.com/fund/apple-tree-partners) 11
- [Novartis Bioventures](https://millionrounds.com/fund/novartis-bioventures) 10
- [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 10
- [SR One](https://millionrounds.com/fund/sr-one) 10
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 9

**Pitching Novartis Venture Fund?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Novartis Venture Fund. A count of rooms they were both in, not a relationship either has claimed.

[**Roche Venture Fund** Corporate VC **15** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**Apple Tree Partners** VC firm **11** rounds together](https://millionrounds.com/fund/apple-tree-partners)[**Novartis Bioventures** Growth equity **10** rounds together](https://millionrounds.com/fund/novartis-bioventures)[**Novo Holdings** VC firm **10** rounds together](https://millionrounds.com/fund/novo-ventures)[**SR One** Corporate VC **10** rounds together](https://millionrounds.com/fund/sr-one)[**New Enterprise Associates** VC firm **9** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Sofinnova Investments** VC firm **9** rounds together](https://millionrounds.com/fund/sofinnova-investments)[**ARCH Venture Partners** VC firm **8** rounds together](https://millionrounds.com/fund/arch-venture-partners)[**Astellas Venture Management** Corporate VC **8** rounds together](https://millionrounds.com/fund/astellas-venture-management)[**HealthCare Ventures** Growth equity **8** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**Johnson & Johnson Development Corporation (JJDC)** VC firm **8** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**Lilly Ventures** Corporate VC **8** rounds together](https://millionrounds.com/fund/lilly-ventures)

## Recently backed

The latest companies Novartis Venture Fund put money into.

[**FORE Biotherapeutics** $67M · Jul 2026](https://millionrounds.com/company/fore-biotherapeutics)[**Sidewinder Therapeutics** $137M · Apr 2026](https://millionrounds.com/company/sidewinder-therapeutics)[**EpiBiologics** $107M · Jan 2026](https://millionrounds.com/company/epibiologics)[**NRG Therapeutics** $68M · Sept 2025](https://millionrounds.com/company/nrg-therapeutics)[**AstronauTx** $61M · Oct 2023](https://millionrounds.com/company/astronautx)[**Epsilogen Ltd.** $41M · Mar 2022](https://millionrounds.com/company/epsilogen-ltd)

## Quick answers about Novartis Venture Fund

### What does Novartis Venture Fund invest in?

Novartis Venture Fund invests most often at Series B and Series A (68% of the rounds on record), in sectors such as Molecules, Drug and Pharma.

### How active is Novartis Venture Fund?

153 investments on record, 4 of them in the last 12 months, and it led 5. The most recent was in Jul 2026.

### What has Novartis Venture Fund invested in recently?

Its most recent investments on record: FORE Biotherapeutics (Series D, Jul 2026), Sidewinder Therapeutics (Series B, Apr 2026) and EpiBiologics (Series B, Jan 2026).

### How big are Novartis Venture Fund's cheques?

The median round it joins is $52M.

### Does Novartis Venture Fund lead rounds?

Sometimes: it led 5 of its 153 investments on record (3%).

### Where does Novartis Venture Fund invest?

Most of the companies it backs are in the United States (68%), the United Kingdom (15%) and Switzerland (8%).

### Is Novartis Venture Fund investing now?

Yes: it is actively investing, with 4 investments in the last 12 months.

### Who does Novartis Venture Fund invest alongside?

Most often Roche Venture Fund (15 rounds together), Apple Tree Partners (11 rounds together) and Novartis Bioventures (10 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=novartis-venture-fund) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=novartis-venture-fund)